Geneos Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-400
Closed -$1.87K 2573
2024
Q2
$1.87K Hold
400
﹤0.01% 1899
2024
Q1
$2.97K Hold
400
﹤0.01% 1813
2023
Q4
$4.05K Hold
400
﹤0.01% 1774
2023
Q3
$3.12K Hold
400
﹤0.01% 1856
2023
Q2
$3.29K Hold
400
﹤0.01% 1838
2023
Q1
$2.9K Hold
400
﹤0.01% 1840
2022
Q4
$3.55K Hold
400
﹤0.01% 1785
2022
Q3
$4K Sell
400
-100
-20% -$1.56K ﹤0.01% 1729
2022
Q2
$6K Sell
500
-6
-1% -$80 ﹤0.01% 2127
2022
Q1
$9K Sell
506
-501
-50% -$9.31K ﹤0.01% 2116
2021
Q4
$26K Hold
1,007
﹤0.01% 1746
2021
Q3
$40K Hold
1,007
﹤0.01% 1589
2021
Q2
$55K Hold
1,007
﹤0.01% 1426
2021
Q1
$37K Sell
1,007
-100
-9% -$5.7K ﹤0.01% 1782
2020
Q4
$45K Sell
1,107
-190
-15% -$7.8K ﹤0.01% 1500
2020
Q3
$38K Buy
1,297
+200
+18% +$6.51K ﹤0.01% 1363
2020
Q2
$31K Buy
1,097
+590
+116% +$15.4K ﹤0.01% 1431
2020
Q1
$10K Buy
+507
New +$12.8K ﹤0.01% 1812
2019
Q4
Sell
-507
Closed -$11K 2550
2019
Q3
$11K Hold
507
﹤0.01% 1848
2019
Q2
$12K Hold
507
﹤0.01% 1836
2019
Q1
$12K Sell
507
-200
-28% -$4.53K ﹤0.01% 1773
2018
Q4
$14K Sell
707
-293
-29% -$7.97K ﹤0.01% 1653
2018
Q3
$31K Sell
1,000
-325
-25% -$10.5K ﹤0.01% 1387
2018
Q2
$47K Hold
1,325
﹤0.01% 1076
2018
Q1
$43K Sell
1,325
-200
-13% -$7.13K ﹤0.01% 1051
2017
Q4
$46K Buy
+1,525
New +$38.4K ﹤0.01% 1034

Other funds holding EDIT

Geneos Wealth Management's EDIT Position: Q3 2024 in Review

Geneos Wealth Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 400 shares — an estimated $1.87K sold.

Geneos Wealth Management first reported a position in EDIT in Q4 2017 and held it in 26 quarters. The position peaked at $55K in Q2 2021. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Geneos Wealth Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 400 Editas Medicine shares in Q3 2024, an estimated $1.87K.
  • Geneos Wealth Management first reported a position in Editas Medicine in Q4 2017 and held it in 26 quarters.
  • Geneos Wealth Management's Editas Medicine position peaked at $55K in Q2 2021.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.